Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus erythematosus (SLE), a debilitating autoimmune disease affecting millions of people ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. In September, Elon Musk amplified a post from Autism Capital—a pro-Trump X account ...
This article is intended for informational purposes only. Imagine if your body’s immune system suddenly turned against itself, mistakenly attacking healthy tissues and cells. That’s what the ...
Filing acceptance based on Phase III ALLEGORY data for Gazyva showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE) If approved, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results